Table 3.
Whole body cardiovascular magnetic resonance imaging (WB CVMR) data for each group including magnetic resonance angiography (MRA) scores, standardised stenosis scores (SAS), left ventricular analysis (LVA) and left ventricular late gadolinium enhancement (LGE) results
| Group 1 | Group 2 | Group 3 | |
|---|---|---|---|
| CAD | CVD | PAD | |
| WB-SAS | 4 (2–11.25) | 6 (2-10) | 24 (17.5-30.5) |
| Head/Neck-SAS | 2.8 (0–5.6) | 8.3 (1.4–9.7) | 19.4 (9.7-25) |
| Aorta-SAS | 8.3 (0–16.7) | 8.3 (8.3-12.5) | 8.3 (8.3-16.7) |
| Abdomen-SAS | 8.3 (0–10) | 0 (0–5) | 20 (5-27.5) |
| Ilio-Femoral-SAS | 6.25 (0–20.8) | 4.2 (2.1–14.6) | 37.5 (27.1-52.1) |
| Run Off-SAS | 0 (0–10.2) | 0 (0–18.7) | 31.3 (11-48.5) |
| LVM (g/m2) | 59.1 (54.1–64.5) | 53.4 (47.4–71.1) | 105.7 (67.8-124.5) |
| EDV (ml/m2) | 74.7 ± 18.8 | 72.4 ± 15.2 | 104.1 ± 34.9 |
| ESV (ml/m2) | 25.3 (18.3–29.7) | 22.4 (17.8–35.8) | 33.8 (22.8-42.8) |
| EF (%) | 64.5 ± 9.8 | 64.7 ± 13.4 | 66.4 ± 11.8 |
| SV (ml/m2) | 46.8 (40.4–52) | 46 (40.2–52.7) | 73.7 (39.4-92.7) |
| LGE | 16 (42.1 %) | 0 (0 %) | 5 (29.4 %) |
Values expressed as Mean ± SD, Median (Interquartile range) or N (%)
CAD coronary artery disease, CVD cerebrovascular disease, PAD peripheral arterial disease, SAS standardised atheroma score, WB whole body, LVM indexed left ventricular mass, EDV indexed end diastolic volume, ESV indexed end systolic volume, EF ejection fraction, SV indexed stroke volume, LGE Late gadolinium enhancement